Baclofen and Vimovo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baclofen (baclofen) and Vimovo (esomeprazole magnesium; naproxen). Common drug interactions include pain in jaw among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Baclofen and Vimovo. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.



On Jul, 16, 2026

60 people who take Baclofen and Vimovo together, and have interactions are studied.

Baclofen and Vimovo drug interactions.

What are the common drug interactions of Baclofen and Vimovo, by gender? *:

female:

  1. Pain in jaw
  2. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Retching (strong involuntary effort to vomit)
  5. Retinal pigmentation (pigmentation of retina)
  6. Road traffic accident
  7. Salivary hypersecretion (excess saliva secretion)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Sinusitis (inflammation of sinus)
  10. Skin ulcer

male:

  1. Dizziness
  2. Chronic kidney disease
  3. Fibromyalgia (a long-term condition which causes pain all over the body)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Haematuria (presence of blood in urine)
  6. Headache (pain in head)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Hypertension (high blood pressure)
  9. Hypotension (abnormally low blood pressure)
  10. Insomnia (sleeplessness)

What are the common drug interactions of Baclofen and Vimovo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Gallbladder disorder
  2. Injection site bruising
  3. Injection site pain
  4. Injection site reaction
  5. Injection site swelling
  6. Migraine (headache)
  7. Nausea (feeling of having an urge to vomit)
  8. Rash
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Cholecystitis (infection of gallbladder)

40-49:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Chest discomfort
  5. Chills (felling of cold)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Dizziness
  8. Drug ineffective
  9. Dyspepsia (indigestion)
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Headache (pain in head)
  4. Gait disturbance
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Haematuria (presence of blood in urine)
  7. Abdominal pain lower
  8. Asthenia (weakness)
  9. Atrioventricular block first degree (heart block first degree)
  10. Balance disorder

60+:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Peripheral swelling
  4. Balance disorder
  5. Cataract (clouding of the lens inside the eye)
  6. Dysarthria (speech disorder)
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Gait disturbance
  9. Memory impairment
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 30.00%
  2. Pain: 12 people, 20.00%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 15.00%
  4. High Blood Pressure: 8 people, 13.33%
  5. High Blood Cholesterol: 8 people, 13.33%
  6. Diabetes: 7 people, 11.67%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 10.00%
  8. Back Pain: 5 people, 8.33%
  9. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 8.33%
  10. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and Vimovo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Baclofen and Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Baclofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Baclofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimovo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on baclofen and esomeprazole magnesium; naproxen (the active ingredients of Baclofen and Vimovo, respectively), and Baclofen and Vimovo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: